Xueyu Hong

470 total citations
6 papers, 178 citations indexed

About

Xueyu Hong is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xueyu Hong has authored 6 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xueyu Hong's work include Glycosylation and Glycoproteins Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and HER2/EGFR in Cancer Research (1 paper). Xueyu Hong is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and HER2/EGFR in Cancer Research (1 paper). Xueyu Hong collaborates with scholars based in China, Denmark and Hong Kong. Xueyu Hong's co-authors include Xun Xu, Wei Zhang, Xiaojing Zeng, Jinghua Wu, Yuanping Du, Xiao Liu, Hongzhi Cao, Chao Nie, Ruifang Zhang and Zheng Su and has published in prestigious journals such as PLoS ONE, Genetics and Biochemical and Biophysical Research Communications.

In The Last Decade

Xueyu Hong

6 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueyu Hong China 6 96 61 49 26 17 6 178
K. J. De Knop Belgium 10 73 0.8× 37 0.6× 17 0.3× 15 0.6× 25 1.5× 12 428
Jordan Oliver Canada 7 159 1.7× 135 2.2× 50 1.0× 6 0.2× 7 0.4× 8 327
Tamara Hilmenyuk Switzerland 5 185 1.9× 64 1.0× 105 2.1× 10 0.4× 15 0.9× 7 337
R Okuyama Japan 5 284 3.0× 34 0.6× 85 1.7× 14 0.5× 9 0.5× 6 345
Odd Kildahl‐Andersen Norway 10 93 1.0× 103 1.7× 46 0.9× 15 0.6× 6 0.4× 29 224
Jeremy Fry United Kingdom 8 105 1.1× 67 1.1× 86 1.8× 50 1.9× 19 1.1× 13 239
Andrew R. Marderstein United States 8 124 1.3× 102 1.7× 35 0.7× 6 0.2× 9 0.5× 10 278
Rebeca Arroyo Hornero United States 7 164 1.7× 40 0.7× 62 1.3× 6 0.2× 14 0.8× 13 244
Ursula Schulte‐Wrede Germany 6 210 2.2× 77 1.3× 48 1.0× 8 0.3× 37 2.2× 7 308
Jolanta Szymańska-Pasternak Poland 9 39 0.4× 93 1.5× 43 0.9× 5 0.2× 15 0.9× 15 220

Countries citing papers authored by Xueyu Hong

Since Specialization
Citations

This map shows the geographic impact of Xueyu Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyu Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyu Hong more than expected).

Fields of papers citing papers by Xueyu Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyu Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyu Hong. The network helps show where Xueyu Hong may publish in the future.

Co-authorship network of co-authors of Xueyu Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyu Hong. A scholar is included among the top collaborators of Xueyu Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyu Hong. Xueyu Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Wei, Rui, Jiayin Yang, Na Li, et al.. (2021). CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson’s disease. JHEP Reports. 4(1). 100389–100389. 26 indexed citations
2.
Wu, Jinghua, Shan Jia, Changxi Wang, et al.. (2016). Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing. Frontiers in Immunology. 7. 28 indexed citations
3.
Liu, Xiao, Wei Zhang, Xiaojing Zeng, et al.. (2016). Systematic Comparative Evaluation of Methods for Investigating the TCRβ Repertoire. PLoS ONE. 11(3). e0152464–e0152464. 35 indexed citations
4.
Zhang, Wei, Yuanping Du, Zheng Su, et al.. (2015). IMonitor: A Robust Pipeline for TCR and BCR Repertoire Analysis. Genetics. 201(2). 459–472. 70 indexed citations
5.
Hou, Sheng, Bohua Li, Ling Wang, et al.. (2008). Humanization of an Anti-CD34 Monoclonal Antibody by Complementarity-determining Region Grafting Based on Computer-assisted Molecular Modelling. The Journal of Biochemistry. 144(1). 115–120. 13 indexed citations
6.
Qian, Weizhu, Ling Wang, Bohua Li, et al.. (2008). Development of new versions of anti-human CD34 monoclonal antibodies with potentially reduced immunogenicity. Biochemical and Biophysical Research Communications. 367(2). 497–502. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026